CARE Ratings Limited
CARE Ratings Limited (CARERATING) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Financial Services›Financial Services›Capital Markets›Ratings
careedge.in(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 96 Cr | 79 Cr | 90 Cr | 79 Cr | 117 Cr | 96 Cr | 110 Cr | 94 Cr | 136 Cr | 112 Cr | 131 Cr | 112 Cr |
| Operating expenses (approx.) | 55 Cr | 55 Cr | 61 Cr | 57 Cr | 62 Cr | 66 Cr | 62 Cr | 66 Cr | 68 Cr | 72 Cr | 70 Cr | 77 Cr |
| EBITDA | 42 Cr | 23 Cr | 29 Cr | 22 Cr | 56 Cr | 30 Cr | 47 Cr | 28 Cr | 68 Cr | 40 Cr | 61 Cr | 35 Cr |
| OPM % | 43.5% | 29.7% | 32.2% | 27.7% | 47.5% | 31.6% | 43.2% | 29.5% | 50.2% | 36.0% | 46.5% | 31.0% |
| Other income | 11 Cr | 14 Cr | 10 Cr | 12 Cr | 12 Cr | 12 Cr | 15 Cr | 14 Cr | 13 Cr | 13 Cr | 16 Cr | 15 Cr |
| Interest | 0.41 Cr | 0.47 Cr | 0.46 Cr | 0.46 Cr | 0.49 Cr | 0.56 Cr | 0.60 Cr | 0.60 Cr | 0.61 Cr | 0.65 Cr | 0.63 Cr | 0.60 Cr |
| Depreciation | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 4 Cr | 4 Cr |
| Profit before tax | 50 Cr | 34 Cr | 36 Cr | 30 Cr | 64 Cr | 39 Cr | 59 Cr | 37 Cr | 77 Cr | 49 Cr | 72 Cr | 45 Cr |
| Tax % | 28.6% | 29.6% | 32.2% | 29.7% | 27.0% | 26.7% | 26.3% | 29.2% | 25.6% | 25.4% | 25.8% | 26.6% |
| Net profit | 36 Cr | 24 Cr | 25 Cr | 21 Cr | 47 Cr | 28 Cr | 43 Cr | 26 Cr | 57 Cr | 37 Cr | 53 Cr | 33 Cr |
| EPS (₹) | ₹11.83 | ₹7.88 | ₹8.07 | ₹6.94 | ₹15.42 | ₹9.30 | ₹14.24 | ₹8.61 | ₹18.90 | ₹11.96 | ₹17.58 | ₹10.73 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 319 Cr | 244 Cr | 248 Cr | 248 Cr | 279 Cr | 332 Cr | 402 Cr | 473 Cr | Sign in for TTM |
| Operating expenses (approx.) | 144 Cr | 162 Cr | 153 Cr | 168 Cr | 180 Cr | 220 Cr | 247 Cr | 276 Cr | Sign in for TTM |
| EBITDA | 175 Cr | 81 Cr | 96 Cr | 80 Cr | 99 Cr | 112 Cr | 155 Cr | 197 Cr | Sign in for TTM |
| OPM % | 54.8% | 33.4% | 38.5% | 32.1% | 35.6% | 33.8% | 38.6% | 41.7% | Sign in for TTM |
| Other income | 30 Cr | 31 Cr | 31 Cr | 27 Cr | 38 Cr | 47 Cr | 51 Cr | 55 Cr | Sign in for TTM |
| Interest | 0 Cr | 0.93 Cr | 0.62 Cr | 0.46 Cr | 1 Cr | 2 Cr | 2 Cr | 2 Cr | Sign in for TTM |
| Depreciation | 3 Cr | 8 Cr | 8 Cr | 8 Cr | 11 Cr | 10 Cr | 12 Cr | 14 Cr | Sign in for TTM |
| Profit before tax | 202 Cr | 104 Cr | 119 Cr | 99 Cr | 126 Cr | 147 Cr | 192 Cr | 235 Cr | Sign in for TTM |
| Tax % | 31.6% | 19.8% | 23.3% | 22.1% | 32.0% | 30.1% | 27.2% | 26.2% | Sign in for TTM |
| Net profit | 138 Cr | 83 Cr | 91 Cr | 77 Cr | 85 Cr | 103 Cr | 140 Cr | 174 Cr | Sign in for TTM |
| EPS (₹) | ₹46.66 | ₹27.96 | ₹30.38 | ₹25.45 | ₹28.17 | ₹33.77 | ₹45.89 | ₹57.06 | Sign in for TTM |
| Dividend payout % | — | — | — | 49.9% | 69.9% | 65.2% | 39.2% | 33.6% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 29 Cr | 29 Cr | 29 Cr | 30 Cr | 30 Cr | 30 Cr | 30 Cr | 30 Cr |
| Reserves | 521 Cr | 504 Cr | 559 Cr | 618 Cr | 643 Cr | 687 Cr | 776 Cr | 902 Cr |
| Borrowings | — | — | — | — | — | 20 Cr | — | — |
| Other liabilities | 63 Cr | 86 Cr | 83 Cr | 80 Cr | 92 Cr | 98 Cr | 142 Cr | 162 Cr |
| Total liabilities | 615 Cr | 619 Cr | 672 Cr | 727 Cr | 771 Cr | 842 Cr | 958 Cr | 1,105 Cr |
| Fixed assets (net) | 74 Cr | — | — | — | 80 Cr | 98 Cr | 80 Cr | 81 Cr |
| CWIP | — | — | — | — | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Investments | 439 Cr | — | — | — | 44 Cr | 44 Cr | 134 Cr | 87 Cr |
| Loans & advances | 0.66 Cr | — | — | — | 0.29 Cr | 0.95 Cr | 1 Cr | 2 Cr |
| Trade receivables | 47 Cr | — | — | — | 22 Cr | 22 Cr | 32 Cr | 35 Cr |
| Cash & bank | 20 Cr | — | — | — | 49 Cr | 38 Cr | 49 Cr | 43 Cr |
| Other assets | 35 Cr | 619 Cr | 672 Cr | 727 Cr | 576 Cr | 638 Cr | 662 Cr | 857 Cr |
| Total assets | 615 Cr | 619 Cr | 672 Cr | 727 Cr | 771 Cr | 842 Cr | 958 Cr | 1,105 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 68 Cr | 82 Cr | 91 Cr | 123 Cr | 148 Cr |
| Cash from investing | — | — | — | -27 Cr | 13 Cr | -39 Cr | -58 Cr | -95 Cr |
| Cash from financing | — | — | — | -35 Cr | -63 Cr | -63 Cr | -54 Cr | -59 Cr |
| Net cash flow | — | — | — | 6 Cr | 32 Cr | -11 Cr | 11 Cr | -6 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 49 Cr | 71 Cr | 82 Cr | 108 Cr | 139 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 36.5% | 19.7% | 20.3% | 15.3% | 18.7% | 19.9% | 23.8% | 25.2% |
| ROE % | 24.9% | 15.4% | 15.2% | 11.6% | 12.2% | 13.9% | 16.8% | 18.1% |
| Debtor days | 54 | — | — | — | 28 | 25 | 29 | 27 |
| Inventory days | 0 | — | — | — | 0 | 0 | 0 | 0 |
| Days payable | 0 | — | — | — | 13 | 15 | 14 | 11 |
| Cash conversion cycle | 54 | — | — | — | 15 | 10 | 15 | 15 |
| Debt / equity | — | — | — | — | — | 0.03 | — | 0.00 |
| Current ratio | 5.71 | — | — | — | 10.19 | 8.57 | 7.08 | 5.76 |
| Net debt / EBITDA | -0.11 | 0.00 | 0.00 | 0.00 | -0.50 | -0.17 | -0.31 | -0.22 |
Compare with peers
Loading peers…